1. Articles from St. Jude Medical

    1-13 of 13
    1. ILUMIEN III Clinical Trial Results from St. Jude Medical Demonstrate Important Findings with Advanced Intravascular Imaging Technology

      ILUMIEN III Clinical Trial Results from St. Jude Medical Demonstrate Important Findings with Advanced Intravascular Imaging Technology

      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the ILUMIEN III trial met its primary endpoint demonstrating percutaneous coronary intervention (PCI) guided by optical coherence tomography (OCT) to be superior to angiography in stent expansion and procedural success and non-inferior to intravascular ultrasound (IVUS) guided-PCI in post-procedure minimal stent area (MSA). This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161030005014/en/ St. Jude Medical™ Optical Coherence Tomography (OCT) Software features automated measurements, co-registered angiography views and new stent deployment features. (Graphic: Business Wire) Results from the ...

      Read Full Article
    2. St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan

      St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan

      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the company’s OPTIS™ Mobile System in Japan and Europe. The diagnostic system is designed to couple state-of-the-art optical coherence tomography (OCT) and angiography co-registration with fractional flow reserve (FFR) technology into one portable system for hospitals with multiple catheterization labs. OPTIS Mobile Integrated Lab (Photo: Business Wire) Driven by a global increase in vascular disease and enabled by advances in technology, the catheterization lab allows physicians to use minimally invasive percutaneous coronary intervention (PCI) procedures that give patients an alternative to open heart ...

      Read Full Article
      Mentions: Abbot
    3. New Data Further Emphasize the Clinical Benefits of St. Jude Medical’s OCT Technology

      New Data Further Emphasize the Clinical Benefits of St. Jude Medical’s OCT Technology

      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary results from the ILUMIEN I trial and final results from the ILUMIEN II clinical study. Taken together, the findings from both studies show that with resolution up to 10 times higher than intravascular ultrasound (IVUS), optical coherence tomography (OCT) imaging can help improve stent selection and deployment, better support clinical decision-making and improve patient outcomes. Data from both studies were presented today as late-breaking clinical trials at EuroPCR 2015, and further advance the use of OCT imaging alongside percutaneous coronary intervention (PCI). During PCI procedures, physicians ...

      Read Full Article
    4. St. Jude Medical Announces Launch of OPTIS Integrated System

      St. Jude Medical Announces Launch of OPTIS Integrated System

      The OPTIS™ Integrated System combines OCT imaging with angiography to provide more detailed, on-demand coronary assessment for more accurate PCI guidanc e St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the company has secured CE Mark and FDA clearance for the new OPTIS Integrated System. The system is a departure from traditional, mobile cart-based diagnostic tools and advances percutaneous coronary intervention (PCI) optimization via direct installation into a hospital’s cardiac catheterization laboratory, fully integrating optical coherence tomography (OCT) and fractional flow reserve (FFR) into PCI workflow. The approval of the OPTIS Integrated system marks ...

      Read Full Article
    5. St. Jude Medical Recognized as Innovative Technology Supplier of the Year by Nation’s Largest Health Care Contracting Organization

      St. Jude Medical Recognized as Innovative Technology Supplier of the Year by Nation’s Largest Health Care Contracting Organization

      St. Jude Medical, Inc . ( STJ ), a global medical device company, was recognized by Novation as the 2013 Innovative Technology Supplier of the Year. Novation members selected the St Jude Medical ILUMIEN™ PCI Optimization System based on their experience using the technology to deliver improved patient outcomes. Novation works with its more than 100,000 members and affiliates to identify innovative technology that improves patient care or reduces the risk of harm to patients or providers, while simultaneously raising the standard of patient care and safety. “Novation’s goals of improving patient outcomes through innovative technology align with our mission at ...

      Read Full Article
      Mentions: Abbot
    6. New 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement Launches in the US

      New 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement Launches in the US

      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and launch of its ILUMIEN ™ OPTIS ™ PCI Optimization ™ System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD). The system will be on display for the first time in the U.S. during the 2013 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The ILUMIEN platform helps physicians better understand which arteries should be treated and how best to treat them. It works by integrating both Fractional Flow Reserve ...

      Read Full Article
    7. St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement

      St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement

      St. Jude Press Release - St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of its ILUMIEN™ OPTIS™ PCI Optimization System™, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD). The system will be on display for the first time in Europe during EuroPCR. 3-D image of a stent inside a coronary artery taken using the ILUMIEN(TM) OPTIS(TM) (Photo: St. Jude Medical, Inc.) The ILUMIEN OPTIS system provides enhancements to the ILUMIEN ™ system, including first-of-its-kind stent planning software tools to ...

      Read Full Article
    8. St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan

      St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan

      St. Jude Medical Press Release - St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of its ILUMIEN ™ OPTIS ™ System, a next-generation technology designed to help physicians make personalized stenting decisions based on each patient’s unique anatomy and disease state. The new ILUMIEN OPTIS system remains the only combined Fractional Flow Reserve (FFR) and intravascular Optical Coherence Tomography (OCT) imaging technology platform. Together, FFR and OCT offer physicians a physiological and anatomical view of the coronary vessels to help diagnose and treat coronary artery disease. The ILUMIEN OPTIS system provides enhancements to the ILUMIEN ...

      Read Full Article
    9. St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

      St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

      St. Jude Medical Press Release - St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first patient enrollment in its ILUMIEN I clinical study. This observational study is designed to show the optimal way Optical Coherence Tomography (OCT), an intravascular imaging technology, combined with the St. Jude Medical PressureWire ™ Aeris , a wireless interventional tool that measures Fractional Flow Reserve (FFR), can guide stent implantation in patients with coronary artery disease. The study will observe and record how physicians treat patients while undergoing Percutaneous Coronary Intervention (PCI), and will also measure outcomes according to various procedural parameters ...

      Read Full Article
    10. St. Jude Medical Board of Directors Authorizes $1 Billion Share Repurchase

      St. Jude Medical Board of Directors Authorizes $1 Billion Share Repurchase

      St. Jude Press Release - St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase of up to $1 billion of its outstanding common stock. The repurchases will occur at such times and at such prices as the management of the company determines and may be effected through transactions in the open market, in privately negotiated transactions or otherwise. As of Nov. 28, 2012, the company had approximately 308 million shares of common stock issued and outstanding. The company expects to fund this program with cash on hand as well as other sources ...

      Read Full Article
    11. Renowned Interventional Cardiologists Discuss Potential Breakthrough of OCT and FFR in the Treatment of Cardiovascular Disease (Video)

      Renowned Interventional Cardiologists Discuss Potential Breakthrough of OCT and FFR in the Treatment of Cardiovascular Disease (Video)
      Renowned Interventional Cardiologists Dr. Augusto Pichard from Washington Hospital Center in Washington DC, Dr. Evelyn Regar from Erasmus Medical Center in The Netherlands, Dr. Francesco Prati from San Giovanni Hospital in Italy, and Dr. Takashi Akasaka from Wakayama Medical University in Japan talk about the tremendous promise of fractional flow reserve (FFR) and Optical Coherence Tomography (OCT) technology used for optimizing percutaneous coronary intervention (PCI), commonly known as coronary angioplasty, one therapeutic procedure used to treat the stenotic (narrowed) coronary arteries of the heart found in coronary heart disease. Both technologies represent potential breakthroughs in the understanding and treatment of ...
      Read Full Article
    12. St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System (Video of Operation and Benefits)

      St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System (Video of Operation and Benefits)

      St. Jude Medical Press Release - St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its ILUMIEN™ system, the first integrated diagnostic technology that combines optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on one platform. The combined system offers physicians advanced physiological and anatomical insight to improve the diagnosis and treatment of coronary artery disease.    The ILUMIEN system features the St. Jude Medical PressureWire™ Aeris, a wireless interventional tool that measures FFR to evaluate the severity of blood flow blockages in the ...

      Read Full Article
      Mentions: Abbot
    13. OCT Intravascular imaging technology platform now available in India

      OCT Intravascular imaging technology platform now available in India
      St. Jude Press Release - Hyderabad – Oct. 18, 2011 – St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the C7-XR™ Optical Coherence Tomography (OCT) Intravascular Imaging System with the C7 Dragonfly™ Imaging Catheter in India. OCT is a next-generation coronary imaging technology platform that aids physicians in the diagnosis and treatment of cardiovascular disease, and is used by interventional cardiologists to assist with stent selection and provide post-stenting information. OCT technology utilizes near-infrared light to create images that go beyond older coronary imaging technologies - such as fluoroscopy and intravascular ultrasound (IVUS) - offering cardiologists an ...
      Read Full Article
      Mentions: Abbot
    1-13 of 13
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics in the News

    1. (13 articles) Abbot
    2. (3 articles) Cardiovascular Research Foundation
    3. (3 articles) Gregg W. Stone
    4. (3 articles) Frank J. Callaghan
    5. (2 articles) Wakayama Medical University
    6. (2 articles) FDA
    7. (2 articles) Giulio Guagliumi
    8. (2 articles) Takashi Akasaka
    9. (2 articles) Harbin Medical University
    10. (1 articles) George Washington University
    11. (1 articles) Evelyn Regar
    12. (1 articles) Nankai University
    13. (1 articles) Medical University of Vienna
    14. (1 articles) Kawasaki Medical School
    15. (1 articles) Stefan G. Sacu
    16. (1 articles) Hector M. Garcia-Garcia
    17. (1 articles) Bo Yu
    18. (1 articles) Ursula Schmidt-Erfurth
    19. (1 articles) Ron Waksman
  3. Popular Articles

  4. Picture Gallery

    OCT Intravascular imaging technology platform now available in India St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System (Video of Operation and Benefits) Renowned Interventional Cardiologists Discuss Potential Breakthrough of OCT and FFR in the Treatment of Cardiovascular Disease (Video) St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization St. Jude Medical Board of Directors Authorizes $1 Billion Share Repurchase St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement St. Jude Medical Announces Launch of OPTIS Integrated System New Data Further Emphasize the Clinical Benefits of St. Jude Medical’s OCT Technology St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan OCT parameters of the optic nerve head and the retina as surrogate markers of brain volume in a normal population, a pilot study Choroidal vessel density in unilateral hyperopic amblyopia using en-face optical coherence tomography